Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Fred Hutchinson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Roswell Park Cancer Institute
University of Nebraska
University of Birmingham
Northside Hospital, Inc.
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Thomas Jefferson University
University of Liege
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Dartmouth-Hitchcock Medical Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute